IL15 and cranioectodermal dysplasia: These results underscore the potential of IL-15-targeted therapies at preventing or repairing intestinal damage induced by gluten and thus represent a promising strategy for the treatment of CeD or inflammatory diseases associated with the overexpression of IL-15.